https://christie.openrepository.com/entities/publication/3066d991-85e8-45c2-b9b0-19c65b6209db
An international expanded-access programme of everolimus: addressing safety and efficacy in...
The RECORD-1 trial established the clinical benefit of everolimus in patients with metastatic renal cell carcinoma (mRCC) after failure of initial vascular...
expanded access programmeinternationaleverolimusaddressingsafety
https://www.knowcancer.com/cancer-trials/NCT00684385/
An Expanded Access Programme With Iressa for Patients With Non-Small-Cell Lung Cancer and Cancer of...
The purpose of this study is to provide ZD1839 for those patients with locally advanced and/or metastatic non-operable non-small cell lung cancer (stage
expanded access programmefor patientssmall celllung cancernon